Business Context and Reporting Period
Lichen International Limited (formerly Lichen China Limited, ticker: LICN) is a Cayman Islands holding company providing financial and taxation solution services, education support services, and software maintenance services primarily in the People's Republic of China (PRC). The company operates through PRC subsidiaries, including Lichen Zixun and Bondly Xiamen. This Form 20-F covers the fiscal year ended December 31, 2024.
The company is classified as an emerging growth company and a foreign private issuer. It recently completed a 1-for-200 reverse stock split in February 2025 to regain compliance with Nasdaq listing requirements.
Key Financial Metrics (Year Ended Dec 31, 2024)
| Metric | 2024 (USD) | 2023 (USD) |
|---|---|---|
| Total Revenue | $41.48 million | $39.76 million |
| Gross Profit | $25.67 million | $24.32 million |
| Operating Loss | $(4.55) million | $12.26 million (Income) |
| Net Loss | $(6.12) million | $8.34 million (Income) |
| Cash and Equivalents | $26.71 million | $25.86 million |
| Total Assets | $79.84 million | $65.55 million |
| Total Liabilities | $4.28 million | $4.13 million |
| Shareholders' Equity | $75.57 million | $61.42 million |
Revenue Breakdown (2024): Financial and taxation solution services ($34.29M, 82.7%); Software and maintenance services ($4.29M, 10.3%); Education support services ($2.90M, 7.0%).
Operating Expenses: Selling and marketing expenses surged to $12.53 million (up 301% YoY) due to multi-channel promotion. General and administrative expenses rose to $17.70 million (up 98% YoY), driven by share-based compensation ($3.41M) and acquisition-related costs.
Material Changes vs. Prior Period
- Profitability Reversal: The company shifted from a net income of $8.34 million in 2023 to a net loss of $6.12 million in 2024. This was primarily caused by a significant increase in operating expenses (selling/marketing and G&A) which outpaced revenue growth.
- Acquisition Activity: In July 2024, the company acquired 60% of Bondly Enterprises Limited (Bondly HK) for $8.0 million, resulting in $4.45 million of goodwill. In February 2025, it acquired the remaining 40% for $5.33 million.
- Capital Raises: The company conducted multiple registered direct offerings in late 2024 and early 2025 (May, December 2024, January 2025) at significantly lower prices ($0.08–$0.70) compared to its 2023 IPO ($4.00), raising approximately $16.5 million in gross proceeds during this period.
- Listing Compliance: The company received a Nasdaq deficiency notice in January 2025 for failing to maintain a $1.00 minimum bid price. It subsequently executed a 1-for-200 reverse stock split and regained compliance in March 2025.
Guidance, Outlook, and Risks
Outlook and Strategy: Management intends to use earnings and capital raised for R&D, specifically developing AI large-scale models for finance and taxation in partnership with JD Technology. The company plans to integrate the DeepSeek optimization framework into its AI model by Q2 2025. No cash dividends are expected in the foreseeable future.
Material Risks:
- Internal Controls: Management identified a material weakness in internal control over financial reporting due to a lack of sufficient accounting personnel with U.S. GAAP expertise and a lack of comprehensive accounting policies. Remediation measures are underway.
- Regulatory Environment (PRC): Significant risks exist regarding PRC regulations on overseas listings (CSRC filing requirements), cybersecurity reviews (CAC), and foreign exchange controls which may restrict the transfer of funds from PRC subsidiaries to the holding company.
- HFCAA and Delisting: While the current auditor (Enrome LLP) is subject to PCAOB inspection, the company faces ongoing risks under the Holding Foreign Companies Accountable Act (HFCAA) regarding auditor inspections and potential delisting if inspections are not maintained.
- Revenue Concentration: Revenue is heavily concentrated in the PRC (99.91% in 2024) and relies on non-recurring financial and taxation solution projects.
Investor Verification Checklist
- Internal Control Remediation: Verify the progress of hiring qualified U.S. GAAP accounting personnel and the implementation of the new financial reporting framework to address the material weakness.
- Capital Structure Dilution: Review the impact of the recent reverse stock split and the series of low-priced registered direct offerings on shareholder dilution and future liquidity.
- PRC Regulatory Compliance: Confirm the status of any required filings with the China Securities Regulatory Commission (CSRC) regarding the company's overseas listing and future offerings.
- AI Integration Progress: Monitor the trial operation and commercial viability of the AI large-scale model developed with JD Technology, as this is a key stated growth driver.
- Dividend Restrictions: Acknowledge that the holding company's ability to pay dividends is restricted by PRC laws requiring statutory reserve allocations and foreign exchange controls on fund repatriation.